Annovis Bio announces special shareholder meeting

Annovis Bio will hold a virtual special shareholder meeting in October 2026.

• Vote on a charter amendment to double authorized common shares to 140,000,000, increase preferred authorization to 10,000,000.
• Consider ratifying the amended 2019 Equity Incentive Plan, setting the share reserve at 5,500,000, raising the annual grant cap to 600,000.
• Also seeks approval to adjourn the meeting if needed to secure additional votes on the share authorization, equity plan items.